Primary Peritoneal Serous Adenocarcinoma

Primary Peritoneal Serous Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

60 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 7
Ph III recruiting: 2
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 51–60 of 60 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00551070	Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer	completed	Phase 2	52	National Cancer Institute (NCI)NIH	1	Dec 3, 2020	clinicaltrials
NCT02283658	Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer	completed	Phase 2	20	Mayo ClinicOTHER	1	Oct 23, 2020	clinicaltrials